Genetics of Interferon Response
The interferon response is the primary antiviral signalling cascade, producing type I interferons that establish an antiviral state in host cells. Genetic variants in interferon production and signalling pathways are among the most strongly associated with COVID-19 severity.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Interferon Response?
Type I interferons (IFN-alpha and IFN-beta) are produced within hours of viral infection by infected cells via activation of transcription factors IRF3 and IRF7. They signal through the IFNAR1/2 receptor complex, activating JAK1 and TYK2, which phosphorylate STAT1 and STAT2, inducing hundreds of interferon-stimulated genes (ISGs). This cascade is the body's most potent antiviral defence. Remarkably, autoantibodies neutralising type I interferons — present in approximately 10% of patients with life-threatening COVID-19 — and loss-of-function variants in IRF7, IRF3, and IFNAR2 have been identified as major determinants of COVID-19 severity.
Biological pathways commonly discussed in relation to Interferon Response
Research into Interferon Response and Type I Interferon Signalling has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Ifn Production
IRF3 and IRF7 are transcription factors activated by innate sensing of viral nucleic acids. Variants reducing their activity impair type I interferon production, weakening the antiviral response.
Jak Stat Signalling
IFNAR1/2 signal through JAK1 and TYK2 to phosphorylate STAT1/2. Variants in IFNAR2, JAK1, TYK2, and STAT1/2 affect interferon signalling amplitude and duration.
Isg Induction
Interferon-stimulated genes (OAS1, MX1, IFIT1, ISG15) establish the antiviral state in host cells. Their expression levels and functional activity are influenced by promoter variants and coding SNPs.
Interferon Regulation
USP18 and SOCS1 negatively regulate interferon signalling. Variants affecting these regulators may alter interferon response magnitude and duration.
Key genes studied in relation to Interferon Response
The following genes have been studied in relation to Interferon Response and Type I Interferon Signalling. These genes span the biological pathways most commonly discussed in this area of research.
11 genes total studied in relation to Interferon Response across the ChronicDNA dataset.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Interferon Response. Each variant represents a position in the genome where individuals may carry different alleles.
21 variants total across genes studied in relation to Interferon Response.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Interferon Response.
This is not a diagnostic service. Genetic variants do not determine whether you have Interferon Response, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Interferon Response shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
Why is the interferon response important in COVID-19?
The type I interferon response is the primary early antiviral defence. Impaired interferon production (from IRF7/IRF3 variants or autoantibodies against interferons) has been identified as a major cause of life-threatening COVID-19 in otherwise healthy individuals, establishing interferon genetics as critically important.
What are autoantibodies against interferons?
In approximately 10% of patients with life-threatening COVID-19, autoantibodies neutralising type I interferons are present, effectively mimicking a genetic interferon deficiency. These autoantibodies — more common with age and in males — represent an acquired form of interferon pathway impairment.
Which interferon genes are most associated with COVID-19 severity?
Genome-wide studies have identified variants in IFNAR2, TYK2, IRF7, IRF3, OAS1, and USP18 as associated with COVID-19 severity. IRF7 and IRF3 loss-of-function variants are rare but cause life-threatening COVID-19 in young individuals.
How does interferon genetics relate to Long COVID?
Impaired interferon responses during acute infection may allow greater viral replication and immune damage, potentially contributing to Long COVID pathogenesis. Conversely, dysregulated interferon signalling (including type I interferonopathy) may drive chronic inflammation in some Long COVID patients.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Interferon Response and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
11 genes · 21 variants analysed in relation to Interferon Response